Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Renata Duchnowska
Tamoxifen — No Longer a Golden Standard for Adjuvant Therapy in the Treatment of Premenopausal Patients With Hormone-Sensitive Breast Cancer
Nowotwory
Cancer Research
Oncology
Related publications
Adjuvant Endocrine Therapy in Premenopausal Patients
Breast Care
Surgery
Oncology
Low P27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy
Clinical Cancer Research
Cancer Research
Oncology
Mammographic Density Reduction Is a Prognostic Marker of Response to Adjuvant Tamoxifen Therapy in Postmenopausal Patients With Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Adjuvant Therapy After Preoperative Treatment for Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Adjuvant Tamoxifen – Longer Against Shorter (ATLAS)
Breast Cancer Online
The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Bilateral Salpingo-Oophorectomy Versus GnRH Analogue in the Adjuvant Treatment of Premenopausal Breast Cancer Patients: Cost-Effectiveness Evaluation of Breast Cancer Outcome, Ovarian Cancer Prevention and Treatment
Clinical Drug Investigation
Medicine
Pharmacology
MiR-4653-3p and Its Target Gene FRS2 Are Prognostic Biomarkers for Hormone Receptor Positive Breast Cancer Patients Receiving Tamoxifen as Adjuvant Endocrine Therapy
Oncotarget
Oncology
Cost-Effectiveness of Anastrozole, in Comparison With Tamoxifen, in the Adjuvant Treatment of Early Breast Cancer in Brazil
Revista da Associacao Medica Brasileira
Medicine
